Citation Impact
Citing Papers
Vascular Klotho Deficiency Potentiates the Development of Human Artery Calcification and Mediates Resistance to Fibroblast Growth Factor 23
2012 Standout
KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD)
2009 Standout
FRAX™ and the assessment of fracture probability in men and women from the UK
2008 Standout
Executive summary of the 2017 KDIGO Chronic Kidney Disease–Mineral and Bone Disorder (CKD-MBD) Guideline Update: what’s changed and why it matters
2017 Standout
Toxicity, mechanism and health effects of some heavy metals
2014 Standout
Can the Nephrologist Prevent Dialysis-Related Amyloidosis?
1991
Post Transplant Erythrocytosis in Hypercalcemic Renal Transplant Recipients
2003
Renal bone disease: a new conceptual framework for the interpretation of bone histomorphometry
2003
Variation in Serum and Plasma PTH Levels in Second-Generation Assays in Hemodialysis Patients: A Cross-sectional Study
2008
Relationship between serum magnesium and parathyroid hormone levels in hemodialysis patients
1999
Regulation of the Voltage Gated K<sup>+</sup> Channel K<sub>v1.3</sub> by Recombinant Human Klotho Protein
2014 Standout
Elastomeric high‐mineral content hydrogel‐hydroxyapatite composites for orthopedic applications
2008 StandoutNobel
Evidence for abnormal calcium homeostasis in patients with adynamic bone disease
1994
Frequency of adynamic bone disease and aluminium storage in Italian uraemic patients--retrospective analysis of 1429 iliac crest biopsies
1996
Aluminium toxicity: its relationship with bone and iron metabolism
1996
Human Health Risk Assessment for Aluminium, Aluminium Oxide, and Aluminium Hydroxide
2007
Maintenance of Bone Mass in Patients Receiving Dialytic Therapy
1993
The HIV-specific advance directive
1997
Improved assessment of bone turnover by the PTH-(1-84)/large C-PTH fragments ratio in ESRD patients
2001
Retrospective study on the usefulness of radius and lumbar bone density in the separation of hemodialysis patients with fractures from those without fractures
1996
Long-term fracture risk following renal transplantation: a population-based study
2003
Comparison of the Humoral Markers of Bone Turnover and Bone Mineral Density in Patients on Haemodialysis and Continuous Ambulatory Peritoneal Dialysis
2002
Circulating biochemical markers of bone remodeling in uremic patients
1999
Efficacy, Tolerability, and Safety of Lanthanum Carbonate in Hyperphosphatemia: A 6-Month, Randomized, Comparative Trial versus Calcium Carbonate
2005
Magnesium basics
2012 Standout
Cinacalcet HCl, an Oral Calcimimetic Agent for the Treatment of Secondary Hyperparathyroidism in Hemodialysis and Peritoneal Dialysis
2005
Risk Factors for Hip Fracture in Hemodialysis Patients
2002
Impact of Ergocalciferol Treatment of Vitamin D Deficiency on Serum Parathyroid Hormone Concentrations in Chronic Kidney Disease
2007
Interpretation and Clinical Significance of Alkaline Phosphatase Isoenzyme Patterns
1994
Spectrum of renal bone disease in end-stage renal failure patients not yet on dialysis
2003
Parathormone secretion in peritoneal dialysis patients with adynamic bone disease
2000
A proposed nomenclature and diagnostic criteria for protein–energy wasting in acute and chronic kidney disease
2007 Standout
Vitamin D Deficiency
2007 Standout
The renal osteodystrophy pattern in Brazil and Uruguay: An overview
2003
Fracture Risk after Parathyroidectomy among Chronic Hemodialysis Patients
2007
Mineral Metabolism, Mortality, and Morbidity in Maintenance Hemodialysis
2004 Standout
Vitamin D Receptor Activators Can Protect against Vascular Calcification
2008
Osf2/Cbfa1: A Transcriptional Activator of Osteoblast Differentiation
1997 Standout
Renal Osteodystrophy in Predialysis and Hemodialysis Patients: Comparison of Histologic Patterns and Diagnostic Predictivity of Intact PTH
2002
Quality End-of-Life Care
1999 Standout
Chronic kidney disease
2011 Standout
Klotho Deficiency Causes Vascular Calcification in Chronic Kidney Disease
2010 Standout
Low vs standard calcium dialysate in peritoneal dialysis: differences in treatment, biochemistry and bone histomorphometry. A randomized multicentre study
2004
Bone disease in predialysis, hemodialysis, and CAPD patients: Evidence of a better bone response to PTH
1995
Factors Considered Important at the End of Life by Patients, Family, Physicians, and Other Care Providers
2000 Standout
VITAMIN D IN HEALTH AND DISEASE: The Evolution of Assays for Parathyroid Hormone
2005
The Creation of an Advance Care Planning Process for Patients With ESRD
2007
Serum Phosphate Levels and Mortality Risk among People with Chronic Kidney Disease
2004 Standout
Mechanisms involved in the side effects of glucocorticoids
2002 Standout
Risk factors for reduced bone density in haemodialysis patients
1999
Paricalcitol versus calcitriol in the treatment of secondary hyperparathyroidism
2003
Doxercalciferol safely suppresses PTH levels in patients with secondary hyperparathyroidism associated with chronic kidney disease stages 3 and 4
2004
PHOSPHORUS METABOLISM AND MANAGEMENT IN CHRONIC KIDNEY DISEASE: Renal Osteodystrophy, Phosphate Homeostasis, and Vascular Calcification
2007
Advance Care Planning by or on Behalf of Peritoneal Dialysis Patients in Long-Term Care
2006
Chronic kidney disease and cardiovascular risk: epidemiology, mechanisms, and prevention
2013 Standout
Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease
2011 Standout
Connections between vascular calcification and progression of chronic kidney disease: Therapeutic alternatives
2005
Increased incidence of hip fractures in dialysis patients with low serum parathyroid hormone
2000
Survival following parathyroidectomy among United States dialysis patients
2004
Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients
2002 Standout
Percutaneous bone biopsy in the diagnosis of renal osteodystrophy
2002
Practical considerations in PTH testing
2005
Development of adynamic bone in patients with secondary hyperparathyroidism after intermittent calcitriol therapy
1994
Predictive value of serum parathyroid hormone levels for bone turnover in patients on chronic maintenance dialysis
1995
Importance of low serum intact parathyroid hormone as a predictor of mortality in hemodialysis and peritoneal dialysis patients: 14 years of prospective observation
2001
Magnesium
2000 Standout
Definition, evaluation, and classification of renal osteodystrophy: A position statement from Kidney Disease: Improving Global Outcomes (KDIGO)
2006 Standout
Relationship between intact 1–84 parathyroid hormone and bone histomorphometric parameters in dialysis patients without aluminum toxicity
1995
Pharmacological and clinical properties of calcimimetics: Calcium receptor activators that afford an innovative approach to controlling hyperparathyroidism
2005
Bone mineral density and biochemical markers of bone turnover in patients with predialysis chronic renal failure
1999
Reviews: Clinical Implications of Disordered Magnesium Homeostasis in Chronic Renal Failure and Dialysis
2009
Specific measurement of PTH (1-84) in various forms of renal osteodystrophy (ROD) as assessed by bone histomorphometry
2005
Correlation of bone histology with parathyroid hormone, vitamin D3, and radiology in end-stage renal disease
1993
Biological Markers in the Diagnosis of the Different Forms of Renal Osteodystrophy
2000
The serum protein α2–Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification
2003 Standout
Development and progression of secondary hyperparathyroidism in chronic kidney disease: lessons from molecular genetics
2007
Prevention of Bone Loss in Renal Transplant Recipients
2003
K/DOQI-recommended intact PTH levels do not prevent low-turnover bone disease in hemodialysis patients
2008
Planning for the end of life
2000
Predictors of bone mineral density in patients on hemodialysis
2004
Insulin-like growth factor system components in hyperparathyroidism and renal osteodystrophy
2000
Calciphylaxis is usually non-ulcerating: Risk factors, outcome and therapy
2002
Biochemical markers for non-invasive diagnosis of hyperparathyroid bone disease and adynamic bone in patients on haemodialysis
1996
Osteoprotegerin and bone mineral density in hemodialysis patients
2006
Associations between osteoprotegerin and femoral neck BMD in hemodialysis patients
2007
Intermittent Calcitriol Therapy and Growth in Children with Chronic Renal Failure
1998
The impact of advance care planning on end of life care in elderly patients: randomised controlled trial
2010 Standout
High Prevalence of Low Bone Turnover and Occurrence of Osteomalacia after Kidney Transplantation
2000
Diagnosis, assessment, and treatment of bone turnover abnormalities in renal osteodystrophy
2004
Effects of Sevelamer Hydrochloride and Calcium Carbonate on Renal Osteodystrophy in Hemodialysis Patients
2008
Osteoprotegerin and parathyroid hormone as markers of high-turnover osteodystrophy and decreased bone mineralization in hemodialysis patients
2002
Quality end‐of‐life care
2000
Low Turnover Osteodystrophy and Vascular Calcification Are Amenable to Skeletal Anabolism in an Animal Model of Chronic Kidney Disease and the Metabolic Syndrome
2005
Reconceptualizing Advance Care Planning From the Patient's Perspective
1998
Chronic Kidney Disease
2016 Standout
Achieving NKF-K/DOQI™ bone metabolism and disease treatment goals with cinacalcet HCl
2005
Relative in Vitro Efficacy of the Phosphate Binders Lanthanum Carbonate and Sevelamer Hydrochloride
2007 StandoutNobel
Sevelamer with and without calcium and vitamin D: Observations from a long-term open-label clinical trial
2000
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
The effects of advance care planning on end-of-life care: A systematic review
2014 Standout
Mutation of the mouse klotho gene leads to a syndrome resembling ageing.
1997 Standout
Communication About Serious Illness Care Goals
2014 Standout
Decrease in Thoracic Vertebral Bone Attenuation With Calcium-Based Phosphate Binders in Hemodialysis
2005
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Posttransplant Acidosis and Associated Disorders of Mineral Metabolism in Patients With a Renal Graft
2007
Serum Magnesium Concentration and PTH Levels. Is Long-Term Chronic Hypermagnesemia a Risk Factor for Adynamic Bone Disease?
1997
Vitamin D and Immune Function
2013 Standout
Evidence for preservation of cortical bone mineral density in patients on continuous ambulatory peritoneal dialysis
1996
Comparison of Survival Probabilities for Dialysis Patients vs Cadaveric Renal Transplant Recipients
1993 Standout
Bone Mass and Dynamic Parathyroid Function According to Bone Histology in Nondialyzed Uremic Patients after Long-Term Protein and Phosphorus Restriction
1999
Bone biopsy results and serum bone turnover parameters in uremic children
2000
Development of a Novel Immunoradiometric Assay Exclusively for Biologically Active Whole Parathyroid Hormone 1–84: Implications for Improvement of Accurate Assessment of Parathyroid Function
2001
Bone Mineral Density: Serum Markers of Bone Turnover and Their Relationships in Peritoneal Dialysis
2004
Mineralized bone loss at different sites in dialysis patients
1998
Analysis of fracture prevalence in kidney-pancreas allograft recipients.
1998
Renal Control of Calcium, Phosphate, and Magnesium Homeostasis
2014 Standout
Severely Reduced Production of Klotho in Human Chronic Renal Failure Kidney
2001
Vascular Calcification
2006 Standout
Cortical PQCT Measures Are Associated With Fractures in Dialysis Patients
2006
Low serum levels of alkaline phosphatase of bone origin: a good marker of adynamic bone disease in haemodialysis patients
1996
SYSTEMIC ALUMINUM TOXICITY: EFFECTS ON BONE, HEMATOPOIETIC TISSUE, AND KIDNEY
1996
Bone metabolism and disease in chronic kidney disease
2003
Vascular Calcification
2008 Standout
Works of Carl Saiphoo being referenced
The spectrum of bone disease in end-stage renal failure—An evolving disorder
1993
Non-invasive prediction of aluminum bone disease in hemo- and peritoneal dialysis patients
1992
Renal osteodystrophy in diabetic patients
1993
Aplastic osteodystrophy without aluminum: The role of “suppressed” parathyroid function
1993
Life-sustaining treatment preferences of hemodialysis patients
1995
Erosive azotemic osteoarthropathy
1984
Risk factors for renal osteodystrophy: A multivariant analysis
1995